Industry News

10/09/08Inspire in 2nd Glaucoma Test

Durham-based Inspire Pharmaceuticals has initiated a Phase 1 clinical trial with its second experimental drug for the treatment of glaucoma.

10/08/08Register Now for Science-Business Forum

Join your colleagues October 22 in helping shape the future of North Carolina's bioscience workforce at the Science - Business Partnership Forum: Cultivating Skills for the 21st Century Workplace. This focused, one-day conference will bring together key North Carolina academic...

10/08/08Aldagen Opts Out of IPO

Aldagen has joined other young North Carolina biotech companies in stepping back from a foray into public ownership as Wall Street flails.

10/08/08ScienceDirect Opportunity Deadline Nov. 1

The North Carolina Biotechnology Center's Library is holding its annual consortium to provide desktop access to Elsevier B.V.'s Corporate Edition of ScienceDirect full-text science journals. This will be the fourth year of the consortium, which currently includes 293 researchers from...

10/08/08Feds Give Novozymes $12.3M

Novozymes, the Danish biotechnology company with U.S. headquarters in Franklinton, has received a $12.3 million contract from the U.S. Department of Energy, aimed at reducing the cost of cellulosic ethanol production.

10/08/08Trana Puts $250K Loan to Work

Cary-based Trana Discovery is putting a $250,000 Small Business Research Loan to work commercializing Trana's proprietary technology for quickly identifying new drugs to fight staph infection.

10/07/08BioDelivery Closer to Market

Raleigh-based BioDelivery Sciences is moving closer to FDA market approval for its flagship cancer-pain mouth patch product, ONSOLIS.

10/07/08Biogen Shows Leukemia Hope

A lymphoma treatment developed by Biogen Idec has shown strong promise in a late-stage human clinical trial as a leukemia treatment. Rituxan, combined with two chemotherapy drugs, helped improve survival in leukemia patients compared to chemotherapy alone. The trial is...

10/06/08Salix Reports Good Results

Morriville-based Salix reported positive results in a clinical trial of its traveler's diarrhea drug rifaximin in treating patients with diarrhea-predominant irritable bowel syndrome.

10/06/08Biolex Closes on $60M Infusion

Pittsboro-based Biolex has again parlayed early Biotechnology Center funding support by adding a $60 million Series D round of venture funding to its previous infusions of more than $113 million and expanding its lock on Locteron.

10/03/08WFU Catheter Spinout Opens

Applied Catheter Technologies, a Wake Forest University School of Medicine spin-out, has set up shop in the Piedmont Triad Research Park to develop scar-fighting drug-coated catheters and stents.

10/02/08BioMedomics Gets SBIR II

BioMedomics, an RTP-based biotech company that got early support through a loan from the Biotechnology Center, has received a $750,000 Phase II Small Business Innovation Research contract from the National Institutes of Health.

10/01/08BioSciences Forum On Tap

The fourth annual BioSciences Forum will be held Oct. 31 at the North Carolina Biotechnology Center in Research Triangle Park.

10/01/08BIO 2009 Briefing Set for Nov. 20

People involved in North Carolina's bioscience sector are invited to RSVP to attend a Nov. 20 presentation in Durham on the BIO International 2009 convention, which will be held in Atlanta in May.

09/30/08Mag Says Biogen's Best

Bioogen Idec, which employs some 800 people at its manufacturing facility in Research Triangle Park, has been named "Company of the Year" by Pharmaceutical Executive magazine.

09/30/08Zen-Bio Nets $1.38M SBIR Grant

Research Triangle Park's Zen-Bio, after earlier help from Biotechnology Center loans, notches another successful SBIR grant -- this one a $1.38 million Phase II boost for its diabetes and obesity research.

09/30/08Entegrion Gets $118K Navy Pact

The U.S. Navy signs a $118K first-phase contract with RTP-based Entegrion to develop a dried plasma packaging system for battlefield clotting emergencies.

09/29/08RTI Lands $7.2M Fed Flu Grant

Research Triangle Park-based RTI International will include Durham Hospitals in a $7.2 million U.S. Centers for Disease Control and Prevention study into the effectiveness of neuraminidase inhibitor drugs such as Tamiflu in older patients.

09/29/08Lefkowitz Gets the Medal

Leading Duke University research scientist Robert Lefkowitz, M.D., joined other top American scientists today at the White House to receive the National Medal of Science from President Bush.

09/26/08UNC-CH Eyes Tropical Diseases

The University of North Carolina at Chapel Hill School of Public Health has established a laboratory that uses state-of-the-art molecular and demographic methods to track and map tropical infectious diseases such as malaria.

All Industry News »